You are here
Preoperative and pretreatment investigations for malignant melanoma
Alberta Provincial Cutaneous Tumour Team.
Alberta Health Services, Cancer Care; 2012 Mar. 8 p. (Clinical practice guideline; no. CU-007).
Pre-operative or pre-treatment investigations in patients with malignant melanoma are important for establishing baseline values, confirming or re-evaluating treatment plans, or possibly identifying patients who may be suitable for inclusion in a clinical trial.
In general, care must be taken when interpreting the results of blood or imaging tests, given the relatively low sensitivity of some of these tests.
The recommendations contained in this guideline are a consensus of the Alberta Provincial Cutaneous Tumour Team and are a synthesis of currently accepted approaches to management, derived from a review of relevant scientific literature. Clinicians applying these guidelines should, in consultation with the patient, use independent medical judgment in the context of individual clinical circumstances to direct care.